The global life science market is driven by a wide range of public and private stakeholder interests. Each impacts different elements of the buying process; from product access, to brand selection, payment and use. An effective commercialization strategy organizes a firm’s branding, marketing, selling, distribution, and medical, payer and government affairs to develop sustainable competitive advantage. This holds true for technologies both old and new, and for markets both mature and emerging. Frankel Group can help you characterize the influence and role of each stakeholder, develop a tailored commercialization strategy, and realize extraordinary results.
Our commercialization strategy practice includes:
- Commercial strategy optimization/growth opportunities
- Product launch planning and management
- Brand planning
- Life cycle management strategies
- Customer segmentation and targeting (CELESTIAL MATRIXSM)
- Competitive benchmarking/assessment/white space identification
- Scenario planning and competitive strategies
- Channel strategy/managed care strategies
- Pricing and reimbursement
- Market/product forecasting
- Loss of exclusivity strategy